Bristol-Myers Squibb Announces Dividend Increase

NEW YORK--(BUSINESS WIRE)-- The Board of Directors of Bristol-Myers Squibb Company (NYSE: BMY) today declared an increase of 9.8% percent in the company’s quarterly dividend, beginning in the first quarter of 2020.

The dividend increase will result in a quarterly dividend of forty-five cents ($0.45) per share on the $.10 par value Common Stock of the corporation. The next quarterly dividend will be payable on February 3, 2020, to stockholders of record at the close of business on January 3, 2020.

The directors also declared a quarterly dividend of fifty cents ($0.50) per share on the $2.00 Convertible Preferred Stock of the corporation, payable March 2, 2020 to stockholders of record at the close of business on February 4, 2020.

The directors indicated an expected dividend for the full year of 2020 of $1.80 per share on the $.10 par value Common Stock of the corporation, subject to the normal quarterly review by the Board.

About Bristol-Myers Squibb
Bristol-Myers Squibb is a global biopharmaceutical company whose mission is to discover, develop and deliver innovative medicines that help patients prevail over serious diseases. For more information about Bristol-Myers Squibb, visit us at BMS.com or follow us on LinkedIn, Twitter, YouTube, Facebook, and Instagram.

View source version on businesswire.com: https://www.businesswire.com/news/home/20191205005803/en/

Media:
[email protected]
609-252-3345

Investors:
Tim Power, 609-252-7509, [email protected]
Nina Goworek, 908-673-9711, [email protected]

Source: Bristol-Myers Squibb Company

You May Also Be Interested In

• Hunting PLC (“Hunting” or “the Company” or “the Group”) Results for the Six Months Ended 30 June 2026
• Hofseth BioCare ASA: SECOND QUARTER 2026 FINANCIAL REPORT
• Micware Presents Research Results at the International Conference “IEEE IV 2026”